IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP IV, LLC

Q3 2023 Holdings

Filed 2023-11-13 | 3 holdings | $265.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Tango Therapeutics, Inc.(TNGX)COM87583X109$218.0M19,363,97582.1%
Pliant Therapeutics, Inc.(PLRX)COM729139105$37.0M2,132,86713.9%
Fulcrum Therapeutics, Inc.(FULC)COM359616109$10.4M2,343,1543.9%